Abstract Body

Background: Elucidating the host innate effector mechanisms that control HIV-1 replication at the site of entry during the earliest stages of infection could be instrumental in the development of an effective AIDS vaccine. We reported previously that transmitted founder (TF) viruses are more resistant to the antiviral effects of interferon α (IFNα) than viruses that predominate during chronic infection. Here, we used matched pairs of TF and 6-month (6-mo) consensus infectious molecular clones (IMCs) to identify genetic determinants of IFNα resistance. Methodology: Single genome sequencing (SGS) was used to infer the full-length TF sequence as well as consensus sequences at 45 days, 85 days and 6-mo post-seroconversion from one patient (CH58). In addition, TF and 6-mo genome sequences were derived from 11 longitudinally followed patients (8 subtype C and 3 subtype B). IMCs were synthesized and viral replication was assessed in human CD4+ T-lymphocytes in the presence and absence of IFNα. Results: To characterize the decline in IFNα resistance over time, we analyzed sequential IMCs from a single patient, CH58. In the absence of IFNα, all four viruses replicated with similar kinetics. However, when target cells were pretreated with IFNα, the TF, d45 and d85 viruses replicated nearly 10-fold more efficiently than the corresponding 6-mo virus (p<0.001). To determine whether loss of IFNα resistance was a common phenotype, we compared the replication potential of matched TF/ 6-mo pairs from 11 additional patients. In each case, TF viruses replicated more efficiently than the corresponding 6-mo viruses in the presence of IFNα. This difference was statistically significant (p<0.05) throughout the 11-day replication time course, with the greatest replication increase observed at day 7 post-infection (range 2.3- 10.2 fold). This phenotype was reproduced in CD4+ T-lymphocytes from multiple human donors. Interestingly, we identified two distinct IFNα sensitivity profiles by varying the duration of pretreatment of target cells. For ten pairs, differential replication was observed when cells were pretreated from 4- 24 hours prior to infection, while two pairs only showed differential replication up to 16 hours of pretreatment, and not beyond. IFNα resistance mapped to nucleotide changes in different genes in two pairs. Conclusions: These data demonstrate that antiviral genes up-regulated by IFNα exert significant selective pressure on the transmitted HIV-1 pool, resulting in the establishment of infection by variants that are relatively IFNα resistant. This IFNα resistance declines within 6 months of infection and is subtype independent. Multiple IFNα -stimulated genes likely contribute to this phenotype.